Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Gerhard Prante, a director at Cibus, Inc. (NASDAQ:CBUS), sold 1,150 shares of the company’s Class A common stock on February 4, 2025. The sale comes as the stock trades near its 52-week low of $2.17, having declined over 85% in the past year. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value metrics. The shares were sold at a price of $2.45 each, totaling $2,817. Following this transaction, Prante holds 24,957 shares directly. The sale was conducted automatically as part of a Rule 10b5-1 trading plan that Prante adopted on August 16, 2024. Want deeper insights into insider trading patterns and 13 additional ProTips? Discover comprehensive insider trading analysis with InvestingPro, which offers exclusive research reports for over 1,400 US stocks.
In other recent news, Cibus, a leader in agricultural gene editing, has been the subject of several significant developments. Canaccord Genuity analysts adjusted their outlook on Cibus, lowering the stock’s price target from $20.00 to $18.00, while still maintaining a Buy rating. This comes after Cibus’s announcement of a direct stock offering to generate approximately $22.6 million for the advancement of its gene-edited plant productivity traits and the further development of its soybean platform.
In a separate development, Cibus’s Board of Directors approved a new base salary of $320,000 for executive Carlo Broos. Details on the previous salary or any additional incentives tied to this revision were not disclosed.
Jefferies also adjusted its price target for Cibus, reducing it to $5.00 from the previous $8.00, while maintaining a Hold rating. The firm’s decision is based on Cibus’s careful balance sheet management and the potential for enhanced negotiating power if the European Union approves gene editing.
During its Third Quarter 2024 Earnings Conference Call, Cibus reported a net loss of $201.5 million but expressed optimism about the future. The company highlighted the successful development of the Trait Machine process and partnerships with major seed companies. Cibus plans to launch herbicide-resistant and Pod Shatter Reduction traits in the coming years, targeting significant market opportunities in the U.S., Latin America, and Asia.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.